| Molecular mechanisms of resistance and toxicity associated with platinating agents CA Rabik, ME Dolan Cancer treatment reviews 33 (1), 9-23, 2007 | 1579 | 2007 |
| The gene ontology resource: 20 years and still GOing strong Gene Ontology Consortium Nucleic acids research 47 (D1), D330-D338, 2019 | 1412 | 2019 |
| Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS DL Nicolae, E Gamazon, W Zhang, S Duan, ME Dolan, NJ Cox PLoS Genet 6 (4), e1000888, 2010 | 1234 | 2010 |
| The gene ontology (GO) project in 2006 Gene Ontology Consortium Nucleic acids research 34 (suppl_1), D322-D326, 2006 | 653 | 2006 |
| The gene ontology project in 2008 Gene Ontology Consortium Nucleic acids research 36 (suppl_1), D440-D444, 2008 | 619* | 2008 |
| Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase AE Pegg, ME Dolan, RC Moschel Progress in nucleic acid research and molecular biology 51, 167-223, 1995 | 587 | 1995 |
| High-throughput discovery of novel developmental phenotypes ME Dickinson, AM Flenniken, X Ji, L Teboul, MD Wong, JK White, ... Nature 537 (7621), 508-514, 2016 | 537 | 2016 |
| Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against … ME Dolan, RC Moschel, AE Pegg Proceedings of the National Academy of Sciences 87 (14), 5368-5372, 1990 | 519 | 1990 |
| Gene Ontology annotations and resources Gene Ontology Consortium Nucleic acids research 41 (D1), D530-D535, 2012 | 457 | 2012 |
| The Gene Ontology in 2010: extensions and refinements Gene Ontology Consortium Nucleic acids research 38 (suppl_1), D331-D335, 2010 | 429 | 2010 |
| Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 R Humerickhouse, K Lohrbach, L Li, WF Bosron, ME Dolan Cancer research 60 (5), 1189-1192, 2000 | 402 | 2000 |
| AgBase: a functional genomics resource for agriculture FM McCarthy, N Wang, GB Magee, B Nanduri, ML Lawrence, EB Camon, ... BMC genomics 7 (1), 1-13, 2006 | 298 | 2006 |
| Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents ME Dolan, RB Mitchell, C Mummert, RC Moschel, AE Pegg Cancer research 51 (13), 3367-3372, 1991 | 281 | 1991 |
| The pharmacogenetics research network: from SNP discovery to clinical drug response KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ... Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007 | 275 | 2007 |
| Testicular cancer survivorship: research strategies and recommendations LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ... Journal of the National Cancer Institute 102 (15), 1114-1130, 2010 | 273 | 2010 |
| O6-benzylguanine and its role in chemotherapy. ME Dolan, AE Pegg Clinical Cancer Research 3 (6), 837-847, 1997 | 267 | 1997 |
| Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer EE Vokes, MS Kies, DJ Haraf, K Stenson, M List, R Humerickhouse, ... Journal of Clinical Oncology 18 (8), 1652-1661, 2000 | 261 | 2000 |
| SCAN: SNP and copy number annotation ER Gamazon, W Zhang, A Konkashbaev, S Duan, EO Kistner, DL Nicolae, ... Bioinformatics 26 (2), 259-262, 2010 | 258 | 2010 |
| Mouse models of human AML accurately predict chemotherapy response J Zuber, I Radtke, TS Pardee, Z Zhao, AR Rappaport, W Luo, ... Genes & development 23 (7), 877-889, 2009 | 253 | 2009 |
| Mouse genome database (MGD) 2019 CJ Bult, JA Blake, CL Smith, JA Kadin, JE Richardson Nucleic acids research 47 (D1), D801-D806, 2019 | 245 | 2019 |
